As of 2025-09-18, the EV/EBITDA ratio of Fulgent Genetics Inc (FLGT) is -12.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLGT's latest enterprise value is 589.43 mil USD. FLGT's TTM EBITDA according to its financial statements is -47.97 mil USD. Dividing these 2 quantities gives us the above FLGT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 14.7x | 12.4x |
| Forward P/E multiples | 9.2x - 11.3x | 9.8x |
| Fair Price | (12.96) - (14.97) | (14.66) |
| Upside | -158.8% - -167.9% | -166.6% |
| Date | EV/EBITDA |
| 2025-09-17 | -12.29 |
| 2025-09-16 | -12.23 |
| 2025-09-15 | -12.26 |
| 2025-09-12 | -12.19 |
| 2025-09-11 | -12.43 |
| 2025-09-10 | -12.13 |
| 2025-09-09 | -12.47 |
| 2025-09-08 | -12.44 |
| 2025-09-05 | -12.24 |
| 2025-09-04 | -12.26 |
| 2025-09-03 | -12.28 |
| 2025-09-02 | -12.47 |
| 2025-08-29 | -12.38 |
| 2025-08-28 | -12.29 |
| 2025-08-27 | -12.04 |
| 2025-08-26 | -11.93 |
| 2025-08-25 | -11.97 |
| 2025-08-22 | -12.12 |
| 2025-08-21 | -11.88 |
| 2025-08-20 | -11.87 |
| 2025-08-19 | -11.99 |
| 2025-08-18 | -11.96 |
| 2025-08-15 | -11.80 |
| 2025-08-14 | -12.10 |
| 2025-08-13 | -12.12 |
| 2025-08-12 | -11.64 |
| 2025-08-11 | -11.38 |
| 2025-08-08 | -11.22 |
| 2025-08-07 | -11.25 |
| 2025-08-06 | -11.42 |
| 2025-08-05 | -11.49 |
| 2025-08-04 | -9.95 |
| 2025-08-01 | -10.05 |
| 2025-07-31 | -9.19 |
| 2025-07-30 | -9.39 |
| 2025-07-29 | -9.44 |
| 2025-07-28 | -9.73 |
| 2025-07-25 | -9.95 |
| 2025-07-24 | -9.98 |
| 2025-07-23 | -10.28 |
| 2025-07-22 | -10.12 |
| 2025-07-21 | -9.56 |
| 2025-07-18 | -9.58 |
| 2025-07-17 | -9.80 |
| 2025-07-16 | -9.74 |
| 2025-07-15 | -9.76 |
| 2025-07-14 | -10.43 |
| 2025-07-11 | -10.53 |
| 2025-07-10 | -10.70 |
| 2025-07-09 | -10.72 |